VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 559 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2015. The put-call ratio across all filers is 1.96 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $54,579,000 | -12.6% | 305,968 | +8.8% | 1.79% | -13.2% |
| Q2 2015 | $62,453,000 | -27.5% | 281,128 | -35.2% | 2.06% | -35.2% |
| Q1 2015 | $86,177,000 | -27.7% | 433,880 | -47.9% | 3.18% | -26.6% |
| Q4 2014 | $119,177,000 | -4.9% | 832,762 | -12.8% | 4.33% | -0.1% |
| Q3 2014 | $125,355,000 | +5.1% | 955,449 | +1.0% | 4.33% | +6.1% |
| Q2 2014 | $119,306,000 | +73.4% | 945,972 | +81.2% | 4.08% | +82.1% |
| Q1 2014 | $68,808,000 | – | 521,945 | – | 2.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
| LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
| FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
| Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
| ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
| Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
| Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
| Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
| Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
| Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |